Stock Reports

NOVAREX Co., Ltd. Diversifies Global Customer Base and Enters a Medium- to Long-Term Growth Cycle—NH

Kwon Oh Seok
2026-08-06 08:04:14
[Edaily Reporter Kwon Oh Seok ] NH INVESTMENT & SECURITIES assessed NOVAREX Co., Ltd.(194700), stating, “Diversification of global customers is gaining momentum, starting with expanded exports to GNC,” and added, “We expect the company to enter a medium- to long-term growth cycle as the expansion of the Osong Plant No. 2 coincides with a recovery in the domestic dietary supplement market.” However, the firm did not provide an investment rating or a target price.

NOVAREX Co., Ltd. is South Korea’s largest ODM (Original Design Manufacturer) company for functional health foods, handling everything from product planning and raw material development to formulation design and production.
Baek Jun-ki, an analyst at NH INVESTMENT & SECURITIES, noted, “The company has secured the strongest raw material competitiveness in Korea based on 48 individually approved ingredients,” and analyzed, “GNC, a major client, is actively utilizing live commerce in China and selling products manufactured in Korea to Chinese consumers through so-called ‘cross-border transactions’ (direct purchases from overseas).”
He continued, “The products supplied by the company include multipacks, omega-3, and coenzyme Q10, all of which are core items,” explaining, “Currently, GNC in China accounts for a significant portion of sales, so the company is expanding ODM supply to local distributors in the U.S. and Southeast Asia while simultaneously securing new customers in China.” Exports to the U.S. expanded to approximately 7 billion won last year, and the company expects supply through local distributors in Southeast Asia to gradually increase.
Researcher Baek emphasized, “Following the expansion of its existing Osong plant, the company is proceeding with an additional investment of approximately 61.8 billion won, and after this investment, we expect it to level up into a company capable of achieving total sales of 1 trillion won,” adding, “The domestic dietary supplement market is also showing signs of improvement starting in the second half of 2025, and we anticipate moderate growth.”
The company is projected to post record-high results in 2026, with revenue of 490.3 billion won (up 21.7% year-over-year) and operating profit of 57.0 billion won (up 36.0%). He added, “Based on estimated 2026 earnings, the P/E ratio stands at 6x, indicating the stock is undervalued relative to its peers; however, with exports expected to account for 39% of revenue in 2026, a revaluation is warranted.”

Economy

Corporation

IT·Science

Economy

CHAEVI CO., LTD Reports Record-High Third-Quarter Revenue Amid Growing Demand for Electric Vehicle Charging

CHAEVI CO., LTD CI. (Photo courtesy of CHAEVI CO., LTD) CHAEVI CO., LTD, an electric vehicle charging infrastructure company, posted its highest-ever quarterly revenue in the third quarter, driven b…
2026-11-17 00:01:35

Corporation

OTOKI’s 3Q Operating Profit Falls 34.5%, but… Overseas Sales Show Double-Digit Growth

OTOKI has succeeded in increasing its revenue, driven by strong sales of instant noodles and sauces and rapid overseas growth, despite deteriorating profitability in the domestic market.Ottogi(007310)…
2026-11-16 18:07:59

IT·Science

Rainbow Robotics Reports 3Q Revenue of 13.9 Billion Won… Loss Widens

Rainbow Robotics(277810)reported a widening net loss in the third quarter of this year despite revenue growth. While sales to its largest shareholder, SamsungElectronics, increased, the proportion of …
2026-11-16 18:49:08